NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/07/2025
Back to search
Official data from USPTO
THE LEADING NON-CPAP OSA THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
THE LEADING NON-CPAP OSA THERAPY
ST13
US500000098277258Class
10
Filing
98277258
Registration
7646086
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
01/07/2025
Classification
Registered
Trademark type
Word
Nice classes
10
Filing date
11/19/2023
Registration date
01/07/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/07/2025
Last transaction
01/07/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
11/26/2024
First use in commerce
11/26/2024
Drawing code
4
Owner type
03
Owner location
Pleasanton, CA
Examiner
KENEALY, NATALIE
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
PROSOMNUS SLEEP TECHNOLOGIES, INC.
Representatives
Kayla Jimenez US IP Attorneys, P.C.
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical devices for treating sleep disorders
Publications
History of USPTO decisions and trademark events.
18 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/07/2025
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
12/13/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2024
IUAA
USE AMENDMENT ACCEPTED
12/13/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
12/10/2024
IUAF
USE AMENDMENT FILED
12/10/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
12/10/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/10/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
10/03/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
10/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/03/2024
GNRT
NON-FINAL ACTION E-MAILED
07/03/2024
CNRT
NON-FINAL ACTION WRITTEN
07/03/2024
DOCK
ASSIGNED TO EXAMINER
06/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/07/2024
NWAP
NEW APPLICATION ENTERED
11/19/2023
Continuous trademark protection
Get notified about every new filing that threatens THE LEADING NON-CPAP OSA THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.